Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796453 · ClinicalTrials.gov registry record · NA
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
A NA study of Presbyopia and Astigmatism, sponsored by Alcon Research.
- Active
- Registry status
- NA
- Development phase
- 470
- Enrollment target
- 7
- Study locations
NCT05796453: Active NA study of Presbyopia and Astigmatism, sponsored by Alcon Research.
NCT05796453 is a NA study of Presbyopia and Astigmatism that is active but no longer recruiting, run by Alcon Research. The registered enrollment target is 470 participants, above the 258-participant average among 38 other Presbyopia trials with a reported enrollment target (82% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796453, a NA study of Presbyopia and Astigmatism, is active but no longer recruiting, sponsored by Alcon Research.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Primary Outcome
BCDVA will be assessed at a distance of 4 meters using letter charts and recorded in logarithm Minimum Angle of Resolution (logMAR).
Conditions Studied
Interventions
- DEVICE Clareon Vivity IOL - Non Toric
- DEVICE Clareon Vivity IOL - Toric
- DEVICE Clareon PanOptix Trifocal IOL - Non Toric
- DEVICE Clareon PanOptix Trifocal IOL - Toric
Study Locations (7)
California
- Wolstan & Goldberg Eye Associates - Torrance
Florida
- Levenson Eye Associates - Jacksonville
New York
- Eye Surgeons of CNY - Liverpool
Oklahoma
- Tulsa Ophthalmology - Tulsa
Texas
- Chu Eye Institute - Fort Worth
Utah
- The Eye Institute of Utah - Salt Lake City
Other
- Centro Oftalmologico Metropolitano - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2028-06 |
| Phase | NA |
What the registry record for NCT05796453 still lists
NCT05796453 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, above the 258-participant average among 38 other Presbyopia trials with a reported enrollment target (82% higher).
The record links to 3 conditions, with Presbyopia appearing as the primary indexed condition, and to 4 interventions - of which Clareon Vivity IOL - Non Toric is the first listed.
NCT05796453 lists 7 locations in 7 states (California, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT05796453 about?
NCT05796453 is a clinical study titled "Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix". The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
What is the current status of trial NCT05796453?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2023-09-19. Estimated completion is 2028-06.
What conditions does trial NCT05796453 study?
This clinical trial studies the following conditions: Presbyopia, Astigmatism, Aphakia.
What interventions are being tested in trial NCT05796453?
The interventions under investigation include: Clareon Vivity IOL - Non Toric (DEVICE), Clareon Vivity IOL - Toric (DEVICE), Clareon PanOptix Trifocal IOL - Non Toric (DEVICE), Clareon PanOptix Trifocal IOL - Toric (DEVICE).
Who is sponsoring clinical trial NCT05796453?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796453 being conducted?
This trial has 7 study locations across California, Florida, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05796453's enrollment target sits among peer trials
470 3rd of 38 higher than 36 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
-
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI